Cargando…

Discovery of the Lyme Disease Agent

A detailed first-hand account of the events leading up to the discovery of the Lyme disease agent has been lacking. Nearly 40 years have elapsed since the discovery of the organism that was named Borrelia burgdorferi. There are thousands of articles in the scientific and medical literature on this o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbour, Alan G., Benach, Jorge L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751065/ https://www.ncbi.nlm.nih.gov/pubmed/31530679 http://dx.doi.org/10.1128/mBio.02166-19

Ejemplares similares

Lyme disease: the next decade
por: Stricker, Raphael B, et al.
Publicado: (2011)

Comparison of Lyme Disease in the United States and Europe
por: Marques, Adriana R., et al.
Publicado: (2021)

Experimental Infections of the Reservoir Species Peromyscus leucopus with Diverse Strains of Borrelia burgdorferi, a Lyme Disease Agent
por: Baum, Elisabeth, et al.
Publicado: (2012)

Physical Therapist Recognition and Referral of Individuals With Suspected Lyme Disease
por: Shea, Jennifer
Publicado: (2021)

Lyme Disease: A Role for Coenzyme Q10 Supplementation?
por: Mantle, David, et al.
Publicado: (2022)

Lyme disease: the promise of Big Data, companion diagnostics and precision medicine
por: Stricker, Raphael B, et al.
Publicado: (2016)

Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete.
por: Benach, J. L., et al.
Publicado: (1984)

Isolation and cultivation of Lyme disease spirochetes.
por: Barbour, A. G.
Publicado: (1984)

Immunochemical analysis of Lyme disease spirochetes.
por: Barbour, A. G.
Publicado: (1984)

Vector Interactions and Molecular Adaptations of Lyme Disease and Relapsing Fever Spirochetes Associated with Transmission by Ticks
por: Schwan, Tom G., et al.
Publicado: (2002)

Generalizability in two clinical trials of Lyme disease
por: Cameron, Daniel J
Publicado: (2006)

Destroying the Village in Order to Save It: Collateral Damage in the Battle Over Lyme Disease
por: Boyce, Ross M
Publicado: (2022)

Malaria and Lyme disease - the largest vector-borne US epidemics in the last 100 years: success and failure of public health
por: Rochlin, Ilia, et al.
Publicado: (2019)

Epidemiologic features of Lyme disease in New York.
por: Hanrahan, J. P., et al.
Publicado: (1984)

Does Experimental Reduction of Blacklegged Tick (Ixodes scapularis) Abundance Reduce Lyme Disease Incidence?
por: Ostfeld, Richard S., et al.
Publicado: (2023)

“Late You Come: Legislation on Lyme Treatment in an Era of Conflicting Guidelines”
por: Naktin, Jaan Peter
Publicado: (2017)

Horses as a Potential Reservoir of Lyme Borreliosis in Jeju-do, Korea
por: Bae, Jong-Myon
Publicado: (2018)

Lactobacilli and other gastrointestinal microbiota of Peromyscus leucopus, reservoir host for agents of Lyme disease and other zoonoses in North America
por: Milovic, Ana, et al.
Publicado: (2020)

Prevalence of the Lyme disease spirochete in populations of white-tailed deer and white-footed mice.
por: Bosler, E. M., et al.
Publicado: (1984)

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area
por: van den Wijngaard, Cees C, et al.
Publicado: (2017)

Lyme Disease Agent Reservoirs Peromyscus leucopus and P. maniculatus Have Natively Inactivated Genes for the High-Affinity Immunoglobulin Gamma Fc Receptor I (CD64)
por: Barbour, Alan G., et al.
Publicado: (2023)

DNA characterization of Lyme disease spirochetes.
por: Schmid, G. P., et al.
Publicado: (1984)

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
por: Cabrera-Andrade, Alejandro, et al.
Publicado: (2020)

Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.
por: Johnson, S. E., et al.
Publicado: (1984)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Protective Immunity and New Vaccines for Lyme Disease
por: Gomes-Solecki, Maria, et al.
Publicado: (2020)

Cell-based high-throughput screens for the discovery of chemotherapeutic agents
por: Fox, Jennifer T., et al.
Publicado: (2012)

Discovery of the Lyme disease spirochete and its relation to tick vectors.
por: Burgdorfer, W.
Publicado: (1984)

Biomarker discovery and beyond for diagnosis of bladder diseases
por: Jung, Sungyong, et al.
Publicado: (2020)

Molecular Characterization of Borrelia burgdorferi from Case of Autochthonous Lyme Arthritis
por: Brummitt, Sharon I., et al.
Publicado: (2014)

Migratory Passerine Birds as Reservoirs of Lyme Borreliosis in Europe
por: Comstedt, Pär, et al.
Publicado: (2006)

Recent discoveries and advancements in research on the Lyme disease spirochete Borrelia burgdorferi
por: Winslow, Christa, et al.
Publicado: (2019)

The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection
por: Badawi, Alaa
Publicado: (2016)

Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discovery
por: Katanaev, Vladimir L., et al.
Publicado: (2023)

The genome of Peromyscus leucopus, natural host for Lyme disease and other emerging infections
por: Long, Anthony D., et al.
Publicado: (2019)

Metal-dependent gene regulation in the causative agent of Lyme disease
por: Troxell, Bryan, et al.
Publicado: (2013)

Primordial origin and diversification of plasmids in Lyme disease agent bacteria
por: Casjens, Sherwood R., et al.
Publicado: (2018)

Lyme disease in Wisconsin: epidemiologic, clinical, serologic, and entomologic findings.
por: Davis, J. P., et al.
Publicado: (1984)

Chemical Chaperone and Inhibitor Discovery: Potential Treatments for Protein Conformational Diseases
por: Zhao, Jian-Hua, et al.
Publicado: (2007)

A perspective on multi-target drug discovery and design for complex diseases
por: Ramsay, Rona R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sdjb1vbrt2lduajjpafqibssdl